Literatur
- 1
Beutler E, Luzzatto L.
Hemolytic anemia.
Semin Hematol.
1999;
36
38-47
- 2
Fargion S, Cappellini M, Piperno A. et al .
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic
effect in determining iron overload.
Am J Clin Pathol.
1986;
86
645-649
- 3
Iolascon A, Perrotta S, Stewart G.
Red blod cell membrane disorders.
Rev Clin Exp Hematol.
2003;
7(1)
22-56
- 4
Miraglia del Giudice E, Nobili B, Francese M. et al .
Clinical and molecular evaluation of non-dominant hereditary spherocytosis.
Br J Hematol.
2001;
112
42-47
- 5
Delhommeau F, Cynober T, Schischmanoff P O. et al .
Natural history of hereditary spherocytosis during the first year of life.
Blood.
2000;
95
393-397
- 6
Parpart A K, Lorenz P B.
The osmotic resistance (fragility) of human red cells.
J Clin Invest.
1947;
26
636-640
- 7
Young L E, Altman K I, Izzo M J, Swisher S N.
Studies on spontaneous in vitro autohemolysis in hemolytic disorder.
Blood.
1956;
11
977-978
- 8
Iglauer A, Reinhardt D, Schröter W, Pekrun A.
Cryohemolysis test as a diagnostic tool for hereditary spherocytosis.
Ann Hematol.
1999;
78
555-557
- 9
Sharon B J.
Transfusion therapy in congenital hemolytic anemias.
Hematol Oncol Clin North Am.
1994;
8
1053-1086
- 10
Bolton-Maggs P M.
The diagnosis and management of hereditary spherocytosis.
Bail Best Pract Res Clin Haematol.
2000;
13
327-342
- 11
Bader-Meunier B, Gauthier F, Archambaud F, Tchernia G.
Long-term evaluation of the beneficial effect of subtotal splenectomy for management
of hereditary spherocytosis.
Blood.
2001;
97
399-403
- 12
Schilling R F.
Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis.
A personal view.
Br J Haematol.
2009;
145(6)
728-732
- 13
Tavazzi D, Taher A, Cappellini M.
Red blood cell enzyme disorders. An overview.
Pediatr Ann.
2008;
37(5)
303-310
- 14
Pekrun A, Lakomek M, Eber S. et al .
Diagnostik des Pyruvatkinase-Mangels bei erhöhter Retikulozytenzahl.
Dtsch Med Wschr.
1995;
120
1620-1624
- 15
Beutler E.
Glucose-6-posphate dehydrogenase deficiency. A historical perspective.
Blood.
2008;
111(1)
16-24
- 16
Ramsey L T, Woods G T, Callahan L. et al .
Quality of life improvement for patients with sickle cell disease.
Am J Hematol.
2001;
66
155-156
- 17
Olivieri N F, Weatherall D J.
The therapeutic reactivation of fetal hemoglobin.
Hum Mol Genet.
1998;
7
1655-1658
- 18
Karasawa M.
Autoimmune hemolytic anemia.
Nippon Rinsho.
2008;
6(3)
520-523
Prof. Dr. med. Arnulf Pekrun
Pädiatrische Hämatologie/Onkologie
Prof. Hess-Kinderklinik
Klinikum Bremen-Mitte
St. Jürgen Straße 1
28205 Bremen
Phone: 0421-497-5410
Fax: 0421-497-3155
Email: arnulf.pekrun@klinikum-bremen-mitte.de
